A.R.Pharma SRL
1.6 FTEA.R.Pharma reported total assets of €2.09m at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Aug 2026), with 1.6 full-time equivalent.
The score of A.R.Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +56 % Total assets +33 % Headcount (avg FTE) +78 %
Accounts of the company itself (not consolidated).
The full file covers 15 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
A.R.Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
A.R.Pharma's financial analysis
- Solvency70.8%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of A.R.Pharma
A.R.Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0837.766.531
- VAT number
- BE0837766531
- Peppol
- Registered · 0208:0837766531 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Jul 2011
- Registered office
- 6061 Charleroi
- Size
- Micro · 1.6 FTE
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
A.R.Pharma (SRL) has been based in Charleroi since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 157,946 € and equity of €1.48m; its revenue is not published. With 1.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 70.8%, above the median of its sector (41.5%).
Companies similar to A.R.Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apoteken Bosmans - Konings Retail sale of pharmaceutical products Antwerp · balance sheet €2.08m
- Apotheek DE Bauw Retail sale of pharmaceutical products Asse · balance sheet €2.09m
- Pharmacie Namur Retail sale of pharmaceutical products Anderlues · balance sheet €2.10m
- BB Farma Management Retail sale of pharmaceutical products Riemst · balance sheet €2.10m
- Portpharma Retail sale of pharmaceutical products Bruges · balance sheet €2.04m
- Westlaanapotheek Retail sale of pharmaceutical products Roeselare · balance sheet €2.04m
- Cobra Apotheek Retail sale of pharmaceutical products Mol · balance sheet €2.02m
- Almey-De Groote Retail sale of pharmaceutical products Kaprijke · balance sheet €2.16m
Frequently asked questions about A.R.Pharma
What is the revenue of A.R.Pharma?
A.R.Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of A.R.Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0837766531 for A.R.Pharma, if the company is VAT-registered. Its company number (CBE) is 0837.766.531.
Where is the registered office of A.R.Pharma?
According to the CBE register, the registered office of A.R.Pharma is in 6061 Charleroi.
What is the equity of A.R.Pharma?
At the close of the 2025 financial year, the equity of A.R.Pharma amounts to 1,478,909 €, a solvency of 70.8% of total assets.
How many people work at A.R.Pharma?
1.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages A.R.Pharma?
The register lists 1 active mandates at A.R.Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of A.R.Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →